These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 178126)

  • 41. Surface antigens of Bordetella pertussis.
    Parker CD; Armstrong SK; Frank DW
    Adv Exp Med Biol; 1985; 185():117-27. PubMed ID: 2866677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physico-chemical analysis of Bordetella pertussis antigens.
    Bolgiano B; Crane DT; Xing D; Williams L; Jones C; Corbel MJ
    Biologicals; 1999 Jun; 27(2):155-62. PubMed ID: 10600205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The specificity of antisera against Bordetella pertussis examined by bacterial agglutination.
    Fredriksen JH; Frøholm LO; Kjennerud U
    Acta Pathol Microbiol Immunol Scand B; 1987 Dec; 95(6):363-9. PubMed ID: 2894108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.
    Pittman M
    Rev Infect Dis; 1979; 1(3):401-12. PubMed ID: 233166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins.
    Altindiş E; Tefon BE; Yildirim V; Ozcengiz E; Becher D; Hecker M; Ozcengiz G
    Vaccine; 2009 Jan; 27(4):542-8. PubMed ID: 19028538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bordetella pertussis agglutinogens in cultivation dynamics].
    Basnak'ian IA; Aleksakhina NN; Shelemekh OV; Miriasova LV; Siundiukova RA
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (3):37-42. PubMed ID: 17672129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between Bordetella pertussis agglutinogen 2 and fimbriae.
    Carter EJ; Preston NW
    J Med Microbiol; 1984 Aug; 18(1):87-94. PubMed ID: 6146723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Purified K-agglutinogen of Bordetella pertussis and its properties.
    Nakase Y; Kasuga T
    Jpn J Microbiol; 1971 May; 15(3):247-56. PubMed ID: 4330023
    [No Abstract]   [Full Text] [Related]  

  • 49. [Glutamine synthetase content and immunochemical analysis of different strains of Bordetella pertussis].
    Samsonova VS; Shakirova RG; Mamaeva EA; Bakulina NA; Efimova OG
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):29-33. PubMed ID: 2875579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The location of surface antigens of Bordetella pertussis by immuno-electron microscopy.
    Ashworth LA; Dowsett AB; Irons LI; Robinson A
    Dev Biol Stand; 1985; 61():143-51. PubMed ID: 2872100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative antigenic activity of the first phase of a whooping cough culture and of an agglutinogen obtained from this culture].
    MASHKOV AV; MIKHAILOVA ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Jul; 31():103-8. PubMed ID: 13767757
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of values of antibody to Bordetella pertussis antigens in young German and American men.
    Cherry JD; Beer T; Chartrand SA; DeVille J; Beer E; Olsen MA; Christenson PD; Moore CV; Stehr K
    Clin Infect Dis; 1995 May; 20(5):1271-4. PubMed ID: 7620009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of specific Bordetella pertussis antibodies in immunoenzyme analysis for detecting the pertussis antigen].
    Titova EI; Gladkova TA; Vaneeva LI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Sep; (9):99-103. PubMed ID: 2891233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymorphonuclear leukocyte-inhibitory factor of Bordetella pertussis. II. Localization in the outer membrane.
    Imagawa T; Sonoda S; Kanoh M; Utsumi S
    Biken J; 1979 Mar; 22(1):1-10. PubMed ID: 43725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mouse or man? Which are pertussis vaccines to protect?
    Preston NW; Stanbridge TN
    J Hyg (Lond); 1976 Apr; 76(2):249-56. PubMed ID: 177701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Physicochemical and immunobiological properties of the dialysate antigen of Bordetella pertussis].
    Iagovkina VV; Moskalenko EP
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Dec; (12):11-5. PubMed ID: 2895557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antipertussis immune response after 2 and after 3 doses respectively of diphtheria-tetanus-pertussis trivaccine.
    Andreescu V; Caffé I; Marion M; Ivan I; Cuteanu I; Barbu I
    Arch Roum Pathol Exp Microbiol; 1981; 40(3):253-7. PubMed ID: 6277273
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines.
    Blaskett AC; Cox JC
    Epidemiol Infect; 1988 Jun; 100(3):335-44. PubMed ID: 2897927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serological diagnosis of pertussis: evaluation of IgA against whole cell and specific Bordetella pertussis antigens as markers of recent infection.
    Poynten M; Hanlon M; Irwig L; Gilbert GL
    Epidemiol Infect; 2002 Apr; 128(2):161-7. PubMed ID: 12002533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.